via University of South Australia
University of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful condition which affects more than two million Australians and costs the country an estimated $23 billion a year.
Using new state-of-the-art imaging techniques to identify signs of osteoarthritis (OA), UniSA scientists are learning more about changes at the molecular level which indicate the severity of cartilage damage.
A study led by PhD student Olivia Lee and her supervisor Associate Professor Paul Anderson using mass spectrometry imaging (MSI) has mapped complex sugars on OA cartilage, showing different sugars are associated with damaged tissue compared to healthy tissue.
The finding will potentially help overcome one of the main challenges of osteoarthritis research – identifying why cartilage degrades at different rates in the body.
“Despite its prevalence in the community, there is a lot about osteoarthritis that we don’t understand,” Prof Anderson says.
“It is one of the most common degenerative joint diseases, yet there are limited diagnostic tools, few treatment options and no cure.”
Existing OA biomarkers are still largely focused on bodily fluids which are neither reliable nor sensitive enough to map all the changes in cartilage damage.
By understanding the biomolecular structure at the tissue level and how the joint tissues interact in the early stages of osteoarthritis, UniSA researchers say any molecular changes could be targeted to help slow the progression of the disease with appropriate medication or treatment.
Osteoarthritis affects an estimated 2.2 million Australians and more than 300 million people worldwide, with those aged over 45 most at risk. Being female, overweight, and having existing joint injuries increases the risk of getting OA.
In Australia, $3.75 million is spent on joint replacements alone for osteoarthritis patients each year, and other indirect costs related to lost work productivity and loss of wellbeing are estimated to be more than $23 billion a year.
In a recent paper published in the International Journal of Molecular Sciences, Lee and her colleagues from UniSA’s Musculoskeletal Biology Research Laboratory and the Future Industries Institute explore how advances in mass spectrometry imaging (MSI) to detect OA are promising.
“To date, diagnosing osteoarthritis has relied heavily on x-rays or MRI, but these provide limited information and don’t detect biomolecular changes that signal cartilage and bone abnormalities,” Lee says.
“By contrast, alternative imaging methods such as MSI can identify specific molecules and organic compounds in the tissue section.”
MSI has already demonstrated its strengths in identifying biomarkers for different types of cancer, and UniSA researchers are hopeful it can achieve the same for early diagnosis of osteoarthritis.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Are You Getting Enough Vitamin K?on April 9, 2021 at 12:54 pm
Now, a growing body of research suggests that getting adequate amounts can help ward off heart disease, cognitive problems, osteoarthritis and physical disability, making it especially important to ...
- Coronal and axial alignment relationship in Caucasian patients with osteoarthritis of the kneeon April 9, 2021 at 10:54 am
In the present study, we investigated the relationship among the coronal alignment and the rotational profile of the lower extremities in the Caucasian population with end-stage knee osteoarthritis.
- Drugs for Osteoarthritis Pain Market Boosting the Growth Worldwide: Market Dynamics and Trends, Efficiencies Forecast 2027on April 9, 2021 at 1:56 am
Apr 09, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" “Drugs for Osteoarthritis Pain Market” Report 2021 covers strong research on global ...
- BCM-95® Curcumin Powerful Anti-Inflammatory for Knee Osteoarthritison April 6, 2021 at 9:00 am
Results were published in the journal Biomed Central BMC. For the study, 193 patients diagnosed with osteoarthritis of the knee were randomized to receive either turmeric extract (BCM-95®) as a 500 mg ...
- Clinical Studies Find sam® Developed by ZetrOZ Systems Effectively Treats Osteoarthritison April 6, 2021 at 7:23 am
“It’s a win-win for everyone involved.” In 2020, researchers examined the use of sustained acoustic medicine and ultrasound gel to treat 32 patients with moderate to severe pain from knee ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- PARADE Study: Smartphone Sensors May Be Used to Develop Patient-Centric Digital Endpoints in RAon April 7, 2021 at 8:30 am
Researchers assessed the feasibility of analyzing iPhone sensor data collected remotely to derive information on functional ability in RA.
- UCI receives $4.2 million grant to study sporadic inclusion body myositis affecting aging adultson April 6, 2021 at 5:17 pm
The National Institute of Arthritis and Musculoskeletal and Skin Diseases has awarded UCI a 5-year, $4.2 million grant to study sporadic inclusion body myositis (sIBM), which affects aging adults ...
- UCI awarded 5-year, $4.2M grant to study rare muscle disorder affecting aging Americanson April 5, 2021 at 9:00 pm
Irvine, CA - April 6, 2021 - The National Institute of Arthritis and Musculoskeletal and Skin Diseases ... of sIBM disease progression over a two-year period and explore biomarkers associated with the ...
- Biomarker Discovery Could Aid Development of Senolytic Drugs Against Age-Related Disorderson April 5, 2021 at 5:00 am
The list of age-related diseases definitively linked to cellular senescence keeps growing, as does the number of biotech companies racing to develop drugs to eliminate senescent cells,” said Judith ...
- The first non-invasive biomarker to track and verify efficacy of senolytic drugson April 2, 2021 at 8:00 am
Buck Institute researchers have discovered and are developing a novel, non-invasive biomarker test that can ... age-related conditions that range from arthritis to lung disease to Alzheimer's ...